Suppr超能文献

可吸收合成塞治疗肛瘘。

Bioabsorbable synthetic plug in the treatment of anal fistulas.

机构信息

Department of General Surgery, Nuovo Ospedale Civile Sant'Agostino Estense, Modena, Italy.

出版信息

Dis Colon Rectum. 2013 Jun;56(6):774-9. doi: 10.1097/DCR.0b013e3182839824.

Abstract

BACKGROUND

Management of anal fistulas is challenging, because surgeons must aim to obtain complete healing while sparing the sphincter and avoiding fecal incontinence. The optimal treatment method remains unknown.

OBJECTIVE

This study assessed the safety and effectiveness of the use of a new synthetic fistula plug made of bioabsorbable polymers in the treatment of cryptoglandular anal fistulas.

DESIGN

This study is a retrospective review of a database of patient records.

SETTING

: Patients were treated at a general hospital in Italy.

PATIENTS

Forty-eight patients (39 men and 9 women; mean age, 49.9 years) with 49 fistulas were treated with the synthetic plug between November 2009 and March 2012. Types of fistula were as follows: 24 superficial transsphincteric, 18 medium transsphincteric, 5 deep transsphincteric, and 1 medium intersphincteric.

INTERVENTIONS

The fistula tract was cleaned by using curettage, and a synthetic plug was sized to fit the tract and inserted. A draining seton was used preoperatively in 1 patient.

MAIN OUTCOME MEASURES

The outcome measures were complete closure of the fistula, with no discharge/residual fistula (verified by endoanal ultrasonography), perineal pain level (assessed with a visual analog scale), and fecal continence. Follow-up was conducted at 1 week and 1, 3, 6, and 12 months postoperatively.

RESULTS

The overall healing rate was 69.3% (34/49 fistulas, 33/48 patients). Eight patients (24.2%) had healing by 3 months after surgery, 21 patients (63.6%) had healed by 6 months, and 4 patients (12.1%) had healed by 12 months. By 3 months, no patient had perineal pain or fecal incontinence. No plug became dislodged, and no patient had the onset of anal stenosis, bleeding, local infection, or any other complication.

LIMITATIONS

The number of patients and the retrospective nonrandomized nature of the investigation are limitations of this study.

CONCLUSIONS

In patients with cryptoglandular anal fistulas, the use of a bioabsorbable synthetic plug provided a high rate of healing without causing fecal incontinence or other major adverse effects. Larger and randomized studies of this treatment are warranted.

摘要

背景

肛门瘘的治疗具有挑战性,因为外科医生必须在保留括约肌的同时达到完全愈合,并避免粪便失禁。目前仍不清楚最佳的治疗方法。

目的

本研究评估了使用新型生物可吸收聚合物合成瘘管塞治疗隐匿性肛腺瘘的安全性和有效性。

设计

本研究是对患者病历数据库的回顾性分析。

设置

患者在意大利的一家综合医院接受治疗。

患者

48 例患者(39 例男性,9 例女性;平均年龄 49.9 岁)共 49 个瘘管接受了合成塞治疗,治疗时间为 2009 年 11 月至 2012 年 3 月。瘘管类型如下:24 例为浅表经括约肌瘘,18 例为中经括约肌瘘,5 例为深经括约肌瘘,1 例为中括约肌间瘘。

干预措施

通过刮除术清理瘘管腔,然后将合成塞插入合适的瘘管腔中。在 1 例患者中,术前使用引流挂线。

主要观察指标

观察指标包括瘘管完全闭合,无分泌物/残留瘘管(通过腔内超声检查证实),会阴疼痛程度(采用视觉模拟评分法评估)和粪便失禁情况。术后 1 周、1、3、6 和 12 个月进行随访。

结果

总体愈合率为 69.3%(49 个瘘管中的 34 个,48 例患者中的 33 例)。术后 3 个月时,8 例(24.2%)患者愈合,6 个月时 21 例(63.6%)患者愈合,12 个月时 4 例(12.1%)患者愈合。术后 3 个月时,无患者出现会阴疼痛或粪便失禁。无塞子移位,无患者出现肛门狭窄、出血、局部感染或其他并发症。

局限性

患者数量和回顾性非随机研究设计是本研究的局限性。

结论

在患有隐匿性肛腺瘘的患者中,使用生物可吸收合成塞可获得较高的愈合率,且不会导致粪便失禁或其他严重不良影响。有必要进行更大规模和随机的研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验